Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

SABMiller’s Mackay Resumes Chairman Role After Tumor Treatment

SABMiller Plc, the world’s second-biggest brewer, said Graham Mackay resumed his role as non-executive chairman after treatment for a brain tumor.

Mackay returned to the position yesterday after being off work since May, the London-based company said today. John Manser, who had been acting chairman, will return to his former role as deputy chairman and senior independent director.

“The directors are extremely grateful to John Manser for stepping so ably into the breach as acting chairman during my absence, and I personally have relied hugely on his support and wise counsel during what has been a very difficult few months for my family and me,” Mackay said in a statement.

In April, Mackay stepped down early as the brewer’s chief executive officer after undergoing brain surgery. As CEO, he led a slew of acquisitions, including the A$10.5 billion ($9.6 billion) takeover of Foster’s Group Ltd. in 2011. SABMiller generated $23.2 billion in revenue last year and competes with the world’s biggest brewer, Anheuser-Busch InBev NV, as well as Heineken NV and Carlsberg A/S.

Alan Clark, a company veteran of more than two decades, replaced Mackay as CEO.

“I am delighted that the transition of the chief executive’s management responsibilities to Alan Clark has gone so well,” Mackay said in today’s statement.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.